Adenovirus Vascular Endothelial Growth Factor (VEGF) Therapy in Vascular Access - Novel Trinam AGainst Control Evidence

Clinical trial NCT00895479 · TERMINATED

Trial details

NCT number: NCT00895479
Sponsor: Ark Therapeutics Ltd
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2009-04-01
Primary completion: 2011-09-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.